JCM
TEVA icon

Jacobi Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Jacobi Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-116
Closed -$1K – 1229
2021
Q3 		$1K Hold
116
– – ﹤0.01% 1414
2021
Q2 		$1K Sell
116
-78
-40% -$826 ﹤0.01% 1360
2021
Q1 		$2K Hold
194
– – ﹤0.01% 1261
2020
Q4 		$2K Sell
194
-1,200
-86% -$11.5K ﹤0.01% 1180
2020
Q3 		$13K Hold
1,394
– – ﹤0.01% 768
2020
Q2 		$17K Hold
1,394
– – ﹤0.01% 680
2020
Q1 		$13K Sell
1,394
-100
-7% -$1.02K ﹤0.01% 664
2019
Q4 		$15K Hold
1,494
– – ﹤0.01% 686
2019
Q3 		$10K Hold
1,494
– – ﹤0.01% 734
2019
Q2 		$14K Hold
1,494
– – ﹤0.01% 692
2019
Q1 		$23K Sell
1,494
-500
-25% -$8.82K 0.01% 548
2018
Q4 		$31K Hold
1,994
– – 0.01% 459
2018
Q3 		$43K Buy
1,994
+350
+21% +$8.13K 0.01% 443
2018
Q2 		$40K Hold
1,644
– – 0.01% 449
2018
Q1 		$28K Hold
1,644
– – 0.01% 498
2017
Q4 		$31K Hold
1,644
– – 0.01% 464
2017
Q3 		$26K Sell
1,644
-3,617
-69% -$81.4K 0.01% 460
2017
Q2 		$164K Hold
5,261
– – 0.06% 146
2017
Q1 		$168K Buy
5,261
+1,328
+34% +$45.3K 0.09% 110
2016
Q4 		$135K Sell
3,933
-877
-18% -$35K 0.08% 120
2016
Q3 		$218K Sell
4,810
-405
-8% -$21.1K 0.1% 84
2016
Q2 		$262K Buy
+5,215
New +$278K 0.13% 70

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Jacobi Capital Management's TEVA Position: Q4 2021 in Review

Jacobi Capital Management sold out of Teva Pharmaceuticals (TEVA) in Q4 2021, closing a stake of 116 shares — an estimated $1K sold.

Jacobi Capital Management first reported a position in TEVA in Q2 2016 and held it in 22 quarters. The position peaked at $262K in Q2 2016. 450 funds tracked by Wall St. Rank hold TEVA as of Q4 2021.

  • Jacobi Capital Management reported no remaining Teva Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Jacobi Capital Management sold 116 Teva Pharmaceuticals shares in Q4 2021, an estimated $1K.
  • Jacobi Capital Management first reported a position in Teva Pharmaceuticals in Q2 2016 and held it in 22 quarters.
  • Jacobi Capital Management's Teva Pharmaceuticals position peaked at $262K in Q2 2016.
  • 450 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2021.

Based on Jacobi Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.